Cannara Biotech Inc (TSXV:LOVE)
C$ 0.69 0 (0%) Market Cap: 62.11 Mil Enterprise Value: 108.43 Mil PE Ratio: 11.50 PB Ratio: 0.78 GF Score: 55/100

Cannara Biotech Inc at Canaccord Genuity Global Cannabis Conference Transcript

May 18, 2023 / 01:00PM GMT
Release Date Price: C$0.85 (+3.66%)
Unidentified Participant

All right. Thanks, everybody, and thanks for those that are watching online on the webcast. We're going to kick off this track this morning. We're excited to have with us Nick who's the CFO of Cannara Biotech which is a Quebec-based Canadian LP that's done really, really well.

So with that, let me turn over to Nick.

Nick Sosiak
Cannara Biotech Inc. - CFO

So thank you. Welcome, everyone. Thank you for joining me today. My name is Nicholas Sosiak. I'm the Chief Financial Officer of Cannara Biotech. We are a publicly traded company under the TSXV, ticker L-O-V-E, LOVE, and on the OTCQB, ticker LOVFF.

Before I get into it, I wanted to share three key notes. First one takeaway is why I believe Cannara is going to be successful in Canada and dominate Canada? One is our asset base and our location, allowing us to have the lowest cost of production, being in Quebec. Number two is our value proposition, focused on quality and low price. And third is our management team.

I'm the CFO, but I have -- I'm actually proud to say

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot